Recombinant Human ADH1A Protein，His

The study of ADH1A (Alcohol Dehydrogenase 1A) recombinant protein has garnered significant attention due to its vital role in alcohol metabolism and potential implications in various health-related areas, including alcoholism, liver disease, and metabolic disorders. ADH1A is a key enzyme in the conversion of ethanol to acetaldehyde, a critical step in alcohol detoxification, making it a significant target for understanding individual variations in alcohol tolerance and susceptibility to alcohol-related diseases. The recombinant expression of ADH1A allows researchers to obtain large quantities of the protein for in-depth functional studies, including enzymatic activity assays, structural analysis, and interaction with inhibitors or cofactors. Advances in molecular cloning and protein purification techniques have facilitated the generation of highly purified ADH1A, enabling investigations into its kinetic properties and regulation. Furthermore, studying ADH1A at the molecular level can illuminate the mechanisms underlying its polymorphisms, which are known to influence alcohol metabolism in different populations. This research can lead to better therapeutic strategies for managing alcohol-related conditions and contribute to the development of personalized medicine approaches based on genetic predisposition to alcohol's effects. Additionally, exploring the potential role of ADH1A in other metabolic pathways further emphasizes its importance in human health and disease. As our understanding of this enzyme continues to evolve, ADH1A recombinant protein serves as a crucial tool not only for basic science research but also for developing potential clinical applications that address the challenges associated with alcohol consumption and its metabolic consequences.